Login
$LNSR
$5.97 +$0.05 (0.84%) Close

$LNSR 3 SEC Filings

Filed On Filing
05 Jun 2026 Form 3: Rossi Michael A., Interim CFO

No securities owned

06 Jun 2023 Form 3: North Run CAPITAL, Lp, 10% owner and 5 others

Holds 1,100,592 shares of Common Stock

13 Jan 2022 Form 3: Wong Kendra, Principal Accounting Officer

Holds 7,336 shares of Common Stock

02 Feb 2021 Form 3: Weisner Aimee S, Director

No securities owned

02 Feb 2021 Form 3: O'Farrell Elizabeth G., Director

No securities owned

17 Sep 2020 Form 3: Connaughton Alan B., Chief Operating Officer

Holds 212,026 shares of Common Stock

17 Sep 2020 Form 3: Pdl BIOPHARMA, Inc., 10% owner

Holds 8,658,694 shares of Common Stock

17 Sep 2020 Form 3: Curtis Nicholas T, Director

Holds 614,963 shares of Common Stock

17 Sep 2020 Form 3: Mclaughlin John Peter, Director

No securities owned

17 Sep 2020 Form 3: Lindstrom Richard L Md, Director

Holds 171,336 shares of Common Stock

17 Sep 2020 Form 3: Link William J Phd, Director

Holds 427,537 shares of Common Stock

17 Sep 2020 Form 3: Winer Gary M, Director

Holds 21,190 shares of Common Stock

17 Sep 2020 Form 3: Staab Thomas R Ii, Chief Financial Officer

Holds 96,381 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support